Trials / Completed
CompletedNCT05569135
Debridement and Laser Ablation Versus Debridement Alone in Pilonidal Disease
Debridement and Laser Ablation Versus Debridement Alone in Pilonidal Disease: Retrospective Analysis of Mid-term Outcome
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 121 (actual)
- Sponsor
- Istanbul Medipol University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
This study aims to investigate the effect of laser ablation (LA) in minimally invasive management of pilonidal disease (PD). Data of the patients with PD who were eligible for simple debridement have been prospectively collected since March 2018, when laser ablation treatment came into use in our institution. Laser ablation treatment was offered to all eligible patients. All the patients underwent debridement (removal of hair and/or necrotic tissues through pits using a clamp/curette/brush) of PD; LA was added to the procedure in patients who were willing to have LA. The surgical outcome of two procedures was compared. The primary outcome measure was recurrence at 36 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Laser ablation | A diode-laser that has been reported to be safe and effective in several treatments including pilonidal disease, anal fistula, hemorrhoids, and vascular ablation was used to obtain shrinkage of pilonidal cyst |
Timeline
- Start date
- 2018-03-01
- Primary completion
- 2019-10-03
- Completion
- 2022-10-03
- First posted
- 2022-10-06
- Last updated
- 2022-10-06
Locations
1 site across 1 country: Turkey (Türkiye)
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05569135. Inclusion in this directory is not an endorsement.